InvestorsHub Logo

MrCheap

05/02/17 10:02 AM

#13156 RE: MrCheap #13155

The product is being launched in both the U.K. and the U.S. this month, and Coyne Healthcare has forecasted sales of 10.6 million Origine 8™ capsules for 2017 with sales increasing to 24 million for 2018.

Aston Martin

05/02/17 2:22 PM

#13160 RE: MrCheap #13155

Interesting product - Phytofare® Catechin Complex in capsules calle Origine 8™- - never ever mentioned with one word by PLPL within those 5 years I am shareholder now! And, of course, ordered by the partner from South-Africa.
Well, ok, imagine 30 cent per capsule (non-biotech-product: sales price by Plandai) , 1.2 million capsule = $400k ..........not bad after 6 years and 25 million revenues in 2012 ;-)
Well, I would give a tiny chance to PLPL... but the market still doesn't as much as I notice

captainscotty

05/10/17 5:07 PM

#13165 RE: MrCheap #13155

#PLPL: Now thats an order...:-} Go Mr. Cheap..